A detailed history of Mar Vista Investment Partners LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Mar Vista Investment Partners LLC holds 233,588 shares of JNJ stock, worth $35.8 Million. This represents 2.58% of its overall portfolio holdings.

Number of Shares
233,588
Previous 343,124 31.92%
Holding current value
$35.8 Million
Previous $50.2 Million 24.52%
% of portfolio
2.58%
Previous 2.59%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$145.48 - $167.38 $15.9 Million - $18.3 Million
-109,536 Reduced 31.92%
233,588 $37.9 Million
Q2 2024

Aug 01, 2024

SELL
$144.38 - $157.78 $10.5 Million - $11.5 Million
-72,579 Reduced 17.46%
343,124 $50.2 Million
Q1 2024

May 13, 2024

BUY
$155.22 - $162.74 $13.1 Million - $13.7 Million
84,163 Added 25.39%
415,703 $65.8 Million
Q4 2023

Feb 08, 2024

SELL
$145.6 - $158.88 $4.54 Million - $4.96 Million
-31,201 Reduced 8.6%
331,540 $52 Million
Q3 2023

Nov 13, 2023

SELL
$155.75 - $174.48 $4.36 Million - $4.88 Million
-27,974 Reduced 7.16%
362,741 $56.5 Million
Q2 2023

Aug 11, 2023

SELL
$154.35 - $166.11 $3.86 Million - $4.16 Million
-25,018 Reduced 6.02%
390,715 $64.7 Million
Q1 2023

May 11, 2023

BUY
$151.05 - $180.26 $9.14 Million - $10.9 Million
60,519 Added 17.04%
415,733 $64.4 Million
Q4 2022

Feb 13, 2023

SELL
$160.2 - $179.79 $26.9 Million - $30.2 Million
-167,887 Reduced 32.09%
355,214 $62.7 Million
Q3 2022

Nov 08, 2022

SELL
$161.33 - $179.52 $42,752 - $47,572
-265 Reduced 0.05%
523,101 $85.5 Million
Q2 2022

Aug 12, 2022

SELL
$168.19 - $186.01 $12.1 Million - $13.4 Million
-71,797 Reduced 12.06%
523,366 $92.9 Million
Q1 2022

May 13, 2022

BUY
$158.14 - $179.59 $8.4 Million - $9.54 Million
53,104 Added 9.8%
595,163 $105 Million
Q4 2021

Feb 11, 2022

SELL
$155.93 - $173.01 $1.42 Million - $1.57 Million
-9,096 Reduced 1.65%
542,059 $92.7 Million
Q3 2021

Nov 15, 2021

SELL
$161.5 - $179.47 $2.67 Million - $2.97 Million
-16,543 Reduced 2.91%
551,155 $89 Million
Q2 2021

Aug 13, 2021

SELL
$159.48 - $171.07 $17.1 Million - $18.3 Million
-107,202 Reduced 15.88%
567,698 $93.5 Million
Q1 2021

May 17, 2021

SELL
$153.07 - $170.48 $2.18 Million - $2.43 Million
-14,230 Reduced 2.06%
674,900 $111 Million
Q4 2020

Feb 16, 2021

SELL
$137.11 - $157.38 $8.22 Million - $9.43 Million
-59,921 Reduced 8.0%
689,130 $108 Million
Q3 2020

Nov 16, 2020

SELL
$140.38 - $153.83 $4.63 Million - $5.08 Million
-32,993 Reduced 4.22%
749,051 $112 Million
Q2 2020

Aug 13, 2020

SELL
$128.81 - $155.51 $14.7 Million - $17.7 Million
-114,054 Reduced 12.73%
782,044 $110 Million
Q1 2020

May 14, 2020

SELL
$111.14 - $153.99 $4.06 Million - $5.63 Million
-36,556 Reduced 3.92%
896,098 $118 Million
Q4 2019

Feb 13, 2020

BUY
$127.5 - $146.44 $23.6 Million - $27.1 Million
184,783 Added 24.71%
932,654 $136 Million
Q3 2019

Nov 13, 2019

BUY
$126.95 - $142.14 $5.28 Million - $5.91 Million
41,562 Added 5.88%
747,871 $96.8 Million
Q2 2019

Aug 13, 2019

SELL
$131.15 - $144.24 $42,623 - $46,878
-325 Reduced 0.05%
706,309 $98.4 Million
Q1 2019

May 14, 2019

BUY
$125.72 - $139.79 $16.6 Million - $18.5 Million
132,042 Added 22.98%
706,634 $98.8 Million
Q4 2018

Feb 13, 2019

BUY
$122.84 - $147.84 $8.14 Million - $9.8 Million
66,275 Added 13.04%
574,592 $74.2 Million
Q3 2018

Nov 14, 2018

BUY
$121.58 - $142.88 $17.2 Million - $20.2 Million
141,092 Added 38.42%
508,317 $70.2 Million
Q2 2018

Jul 30, 2018

SELL
$119.4 - $131.76 $2.47 Million - $2.73 Million
-20,687 Reduced 5.33%
367,225 $44.6 Million
Q1 2018

May 07, 2018

SELL
$125.1 - $148.14 $337,895 - $400,126
-2,701 Reduced 0.69%
387,912 $49.7 Million
Q4 2017

Feb 07, 2018

BUY
$131.22 - $143.62 $300,362 - $328,746
2,289 Added 0.59%
390,613 $54.6 Million
Q3 2017

Nov 07, 2017

BUY
$129.47 - $135.38 $50.3 Million - $52.6 Million
388,324
388,324 $50.5 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $400B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Mar Vista Investment Partners LLC Portfolio

Follow Mar Vista Investment Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mar Vista Investment Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mar Vista Investment Partners LLC with notifications on news.